Three-dimensional Analysis of EMMPRIN on Conjunctival Epithelial Cells Surface in Severe Dry Eye Syndrome (ALTESSE)
NCT03358979 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2025-12-08
Summary
Modifications of cell surface markers (including EMMPRIN) were observed in conjunctival epithelial cells during dry eye syndrome ; this study aims to describe the modifications of the repartition of these cell surface markers before and after initiation of a treatment.
Conditions
- Conjunctival Diseases
- Dry Eye Syndromes
Sponsors & Collaborators
-
Fondation Ophtalmologique Adolphe de Rothschild
lead NETWORK
Principal Investigators
-
Eric GABISON · Fondation Ophtalmologique A. de Rothschild
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-12-14
- Primary Completion
- 2026-12-31
- Completion
- 2027-03-31
Countries
- France
Study Locations
More Related Trials
-
Mucin Levels in Dry Eye and Normal Populations
NCT05911555 ·Status: COMPLETED
-
Impairment of Reading Ability in Dry Eye Patients
NCT01826812 ·Status: COMPLETED
-
Use of Autologous Serum Eye-drops as Tears in Patients With Recalcitrant Dry Eye
NCT01089985 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Safety and Tolerability of Investigational Ocular Lubricants
NCT05888519 ·Status: COMPLETED ·Phase: NA
-
Proteomic and Metabolomic Lacrimal Fingerprint in Diverse Pathologies of the Ocular Surface
NCT04198740 ·Status: RECRUITING
-
Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome: ARISE-1
NCT02597803 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy of Cyclosporine Ophthalmic Emulsion in the Treatment of Dry Eye Syndrome in Contact Lens Wearers
NCT00335114 ·Status: COMPLETED ·Phase: NA
-
Collection of Ocular Surface Impressions Cytology of the Living Eye From Patients With Dry Eyes or Limbal Stem Cell Deficiency.
NCT06255301 ·Status: COMPLETED
-
Efficacy of the Chronic Application of Tear Formulations
NCT01384851 ·Status: UNKNOWN ·Phase: NA
-
A Safety and Efficacy Study of a New Eye Drop Formulation in Patients With Dry Eye Disease.
NCT02553772 ·Status: COMPLETED ·Phase: PHASE3
-
Differential Diagnosis of Sjögren's Versus Non-Sjögren's Dry Eye
NCT04493658 ·Status: COMPLETED
-
The Effect of a New Emulsion in Dry Eye Patients on Tear Layer Aberrometry, Contrast Sensitivity, and Reading Ability
NCT01013077 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Blink Tears and Systane Concomitant With Restasis for the Treatment of Dry Eye Symptoms
NCT00565669 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate Corneal Neurosensory Abnormalities in Patients With Sjögren's Dry Eye
NCT06411132 ·Status: TERMINATED
-
A Phase 4 Study Investigating the Efficacy of Retaine™ in Managing Signs and Symptoms Associated With Dry Eye Syndrome
NCT02139033 ·Status: COMPLETED ·Phase: PHASE4
-
Study of the TearCare System in Dry Eye Disease
NCT03588624 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Platelet-Rich Plasma Injection in Dry Eye Syndrome
NCT06831253 ·Status: RECRUITING ·Phase: NA
-
PMCF Study to Evaluate Performance and Safety of "HPMC-based Eyedrops" Used to Relieve Dry Eye Symptoms
NCT05825599 ·Status: COMPLETED ·Phase: NA
-
A Safety and Efficacy Study of MIM-D3 Ophthalmic Solution for the Treatment of Dry Eye
NCT01960010 ·Status: COMPLETED ·Phase: PHASE3
-
Autologous Serum Eye Drops in Dry Eye Syndrome
NCT07295691 ·Status: RECRUITING ·Phase: NA
-
Efficacy and Safety of BUFY01 Versus SVS20 in the Treatment of Dry Eye Disease
NCT05865379 ·Status: RECRUITING ·Phase: NA
-
Efficacy and Safety Evaluation of Tavilermide Ophthalmic Solution for the Treatment of Dry Eye
NCT05848128 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome: ARISE-3
NCT03937882 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluating a New Therapy for Dry Eye in Patients With Sjögren's Syndrome
NCT07277257 ·Status: RECRUITING ·Phase: PHASE4
-
Evaluation of the Effect of Repeated Usage on the Tear Film Characteristics of an Investigational Eye Drop in Dry Eye Sufferers
NCT01339936 ·Status: COMPLETED ·Phase: PHASE2/PHASE3